Form 8-K - Current report:
SEC Accession No. 0001144204-17-053962
Filing Date
2017-10-25
Accepted
2017-10-25 08:00:22
Documents
8
Period of Report
2017-10-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv477696_8k.htm 8-K 18442
2 EXHIBIT 99.1 tv477696_ex99-1.htm EX-99.1 7583
3 EXHIBIT 99.1 tv477696_ex99-1.pdf EX-99.1 536033
4 EXHIBIT 99.2 tv477696_ex99-2.htm EX-99.2 7924
5 EXHIBIT 99.2 tv477696_ex99-2.pdf EX-99.2 533890
6 GRAPHIC image_001.jpg GRAPHIC 5687
7 GRAPHIC ex99-1.jpg GRAPHIC 764357
8 GRAPHIC ex99-2.jpg GRAPHIC 754897
  Complete submission text file 0001144204-17-053962.txt   3609794
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 171152090
SIC: 2834 Pharmaceutical Preparations